Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $8.0 million.

  • Alignment Healthcare's Depreciation and Depletion rose 1348.78% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 4828.42%. This contributed to the annual value of $26.4 million for FY2024, which is 2293.63% up from last year.
  • Alignment Healthcare's Depreciation and Depletion amounted to $8.0 million in Q3 2025, which was up 1348.78% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's Depreciation and Depletion ranged from a high of $8.0 million in Q3 2025 and a low of $52000.0 during Q1 2024
  • Moreover, its 5-year median value for Depreciation and Depletion was $4.9 million (2023), whereas its average is $5.1 million.
  • In the last 5 years, Alignment Healthcare's Depreciation and Depletion plummeted by 9893.55% in 2024 and then surged by 1334807.69% in 2025.
  • Alignment Healthcare's Depreciation and Depletion (Quarter) stood at $4.1 million in 2021, then grew by 14.83% to $4.7 million in 2022, then rose by 25.33% to $5.8 million in 2023, then increased by 16.72% to $6.8 million in 2024, then grew by 17.29% to $8.0 million in 2025.
  • Its Depreciation and Depletion stands at $8.0 million for Q3 2025, versus $7.0 million for Q2 2025 and $7.0 million for Q1 2025.